DOCSLIB.ORG

The Galr1-Galr2 Heteroreceptor Complexes Can Be the Receptor for Galanin Fragment 1-15 Dasiel O

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Galr1-Galr2 Heteroreceptor Complexes Can Be the Receptor for Galanin Fragment 1-15 Dasiel O The GalR1-GalR2 heteroreceptor complexes can be the receptor for galanin fragment 1-15 Dasiel O. Borroto-Escuela*, Feliciano Calvo, Manuel Narváez, Wilber Romero-Fernández, Carmelo Millon, Michael Di Palma, Mileidys Pérez Alea, Mercé Tena, Luigi F. Agnati, Alexander Tarakanov, Pere Garriga, Zaida Díaz-Cabiale and Kjell Fuxe * Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Email: [email protected] BACKGROUND Previous work has established homodimerization and internalization of GalR1 in living CHO cells using FRET and time lapse confocal imaging1. Thus, GalR1 can exist as a dimer in the plasma membrane which may undergo desensitization and internalization upon agonist activation with Gal1-29. We have examined the possible existence of GalR-5-HT1A heteromersin HEK-293 cells using a proximity-based FRET assay2. Furthermore, the three cloned galanin receptors show a higher affinity for galaninthan for galaninN-terminal fragments like Gal1-153. A substantial further development was therefore the demonstration of specific Gal1-15 binding sites in the rat CNS indicating a relevant role of Gal fragments in central galanin communication, especially in dorsal hippocampus, neocortex and striatum which show only few high affinity Gal1-29 binding sites4. We have therefore introduced the hypothesis that these Gal1-15 preferring sites may be formed through the formation of GalR1- GalR2 heteroreceptor complexes which leads to conformational changes in their galanin recognition sites converting GalR1 and/or GalR2 into galanin fragment preferring binding sites with reduced affinity for Gal1-295. METHODS & RESULTS We used a dual luciferase reporter assay to indirectly detect variations Figure 1. GalR1-GalR2 heteroreceptor complexes in hipocampal and of cAMP levels, PLC-b activity, or activations of MAPK pathway in median raphe sections of rat detected by In situ PLA. In situ PLA was transiently transfected cell lines treated with different compounds. For performed as described previously6 and using primary antibodies of luciferase assays, cells were co-transfected with plasmids different species directed to GalR1 and GalR2. The detected corresponding to three constructs as follows: 2 g firefly luciferase- heteroreceptor complexes are seen as red clusters indicated by arrows. encoding experimental plasmid (pGL4-CRE-luc2p or pGL4-NFAT- Specific GalR1-GalR2 clusters are visualized within discrete regions of luc2p; 1 g of GalR1 plus GalR2 expression vectors and 0.5 g Rluc- the hippocampus and median raphe. They were almost absent in the encoding internal control plasmid (phRG-B). The luciferase activity of corpus callosum (cc). The relative densities of PLA cluster distributions cell extracts was determined in a POLARstar Optima plate reader using are schematically illustrated by the density of red puncta. Bregma level a 535 nm filter with a 30-nm bandwidth. Firefly luciferase was –1.7 and –7.64. measured as firefly luciferase luminescence over a 15s reaction period. Figure 3. Agonist-induced GalR1 and GaLR2 receptor activation in a DG DRN forskolin-induced CRE-luciferase reporter gene assay. The data represent the mean S.E.M. of five independent experiments performed in quadruplicate. (EC50 ~ 0.92nM in Gal1-15 group and EC50 ~ 35.8nM in the Gal 1-29 group). 120 [GalR1-GalR2 1:1] [GalR2-GalR2 1:1] 120 120 φφφ 80 +++ +++ φφφ 80 80 CREB *** CREB CREB 40 &&& 40 40 (% max response FK, 30 min) 30 FK, response max (% FK, 30response min) (% max (% max response FK, 30 FK,min) 30 response (% max [GalR1-GalR2 1:1] 0 0 0 l M M M M M M -14 -12 -10 -8 -6 -4 -2 µ µ µ µ ro µ µ 1 1 0nM 0nM 1 1 50nM ont 5 5 control 35 c ] 87 871 Log [peptide](M) M 871 1 871 1 M 1-15] M M M [ + [1-15 M + l + + al [1-29] 50nM M + a G 0n G Gal Gal [1-29] 0n ] 5 50nM ] 5 50nM 29 ] ] 50nM Gal [1-15] Gal [1-29] 29 [1- 1-15] [1- [ [1-15 [1-29 Gal Gal [1-15] 50nM + M35 1 Gal Gal Gal Gal +++ [GalR1-GalR2 1:1] [GalR2-GalR2 1:1] 150 *** 200 &&& &&& Figure 4. Agonist-induced *** 150 +++ GalR1 and GaLR2 receptor 100 100 NFAT NFAT ** +++ 50 protomer activation in an 50 (% basal, over 30 min) (% over basal, 30 min) 30 basal, over (% NFAT-luciferase reporter 0 0 M M M M M M µ µ rol nM µ µ nM µ µ ntrol 0nM nt o 5 o 50 50 c gene assay. c ] ] 9 5 2 M871 1 M871 1 M871 1 + [1-29] + M871 1 [1-2 + [1-1 + l M + M35 1 M + M35 1 M a Figure 2. (left) BRET saturation curves for the GalR1-GalR2 n n Gal [1-15] 50nM G nM Gal nM Gal nM 50 50 50n 50 5] -29] [1-1 1 2 al [1-29] al [1-15] G G Gal Gal [ heteromers with increasing expression levels of the GFP tagged GalR2 Gal [1-29] 50 Gal [1-15] 50 receptor. Plotted on the X-axis is the fluorescence value obtained from DISCUSSION & CONCLUSIONS the GFP2, normalized with the luminescence value of GalR1Rluc ! GalR1-GalR2 heteroreceptor complexes exist in cellular models and expression 10 min after coelenterazine incubation. Mean S.E.M.; n = raphe-hippocampal system. 10, in triplicate. The GalR1-GalR2 curve fitted better to a saturation ! Gal1-15 vs Gal1-29 preferentially activates the GalR1 protomer Gi/o curve than to a linear regression as found with mixed pool of cell from mediated signaling cell individually expressing GalR1Rluc + GalR2GFP2 (F test ! Gal1-15 cannot activate the GalR2 (P < 0.01). (right) BRET2 competition experiment for the GalR1- protomer Gq mediated signaling in GalR2 heteromers. the heteromers. GalR1Rluc-GalR2GFP2 ! Gal1-29 strongly increases GalR2 100 BRET = 81.4 3.9 max Gq mediated signaling in GalR1- BRET50 = 1.54 0.13 80 GalR2 heteromers and GalR2 120 homomers. 60 80 ! The dominance of GalR1 vs ratio (mBU) ratio 2 */** 40 signal 2 ** GalR2 induced by Gal1-15 suggests ** pcDNA3.1+ BRET 40 5-HT1A strong depression like actions 20 BRET GalR1 GalR2 [% of max response] 0 0 GalR1-GalR2 BRET pair 1:1 REFERENCES 0 3 6 9 0 2 4 6 8 10 1Wirz SA et al., 2005. Neuropeptides 39,535-546.; 2Borroto-Escuela DO et al., 2010. Biochem Biophys Res 2 2 3 4 (GFP -GFP 0)/Rluc (AU) cDNA (µµµg) Commun 393,767-772.; Branchek T et al., 1998. Ann N Y Acad Sci 863, 94-107.; Hedlund PB et al., 1992. Eur J Pharmacol 224, 203-205.; 5Fuxe K et al., 2008. Brain Res Rev 58, 415-452.; 6Borroto-Escuela DO et al., 2013. GalR1-Rluc/GalR2-GFP 2 control (-) Methods Enzymol 521, 281-294. Copyright © 2014 Dasiel O. Borroto-Escuela, Mobil: + 46 706177287, email: [email protected] Bio-CV Dasiel O. Borroto-Escuela , PhD, MBA Name: Dasiel Oscar Borroto Escuela Birth data: 14/11/1979, Yaguajay-Cuba. Address: Department of Neuroscience. Karolinska Institutet. Retzius väg 8. 17177 Stockholm, Sweden. +46 706 177 287; [email protected] During my doctoral studies (Ph.D. in Polymers and Biopolymers, UPC, Barcelona, Spain), I was focused into the understanding of muscarinic acetylcholine receptor family interacting proteins and their potential roles in receptor function. The conducted research work earned me 5 relevant publication in the field and the UPC Excellence Thesis Award. In the last years, I have mainly focused on understanding the molecular integration of signals in the brain via receptor-receptor interaction and its functional effects. The existence of receptor heteromers with allosteric receptor-receptor interactions markedly increases the diversity of GPCR recognition, trafficking and signalling; a current scientific issue of high relevance to brain function and integration. The starting point of my research projects (Postdoc, Neuro-KI) has been to figure out whether alterations in specific heteromers and their receptor-receptor interactions are associated or considered to play a role in pathogenic mechanisms contributing to brain disease development, inter alia Parkinson's disease, schizophrenia, addiction and depression. To understand the role of receptor heteromers in some of these diseases I have primarily used as models D2likeR, serotonin 5-HT receptor and galanin receptor heteromers as well as GPCR-RTK interaction (5HT1A/FGFR1) through a multidisciplinary approach. I have focused on the interactions between 5-HT1A and FGFR1 receptors and their relevance for neuroplasticity and depression (Borroto- Escuela et al., Biological psychiatry 71, 84-91 (2012) and Borroto-Escuela et al., BBRC. 441(2):387-92 (2013)). Also, on developing and applying both FRET and BRET techniques to demonstrate a direct molecular receptor-receptor interaction and more recently to develop in situ Proximity Ligation Assay to demonstrate the existence of heteroreceptor complexes in the brain (Borroto-Escuela et al., Methods in enzymology 521, 281-294 (2013)). I have been specially interested in the study of serotonin 5-HT1A receptor containing heteroreceptor complexes and their relevance for neurological disorders (Borroto- Escuela et al., BBRC 393(4):767-72 (2010) and Borroto-Escuela et al., BBRC 441(2):387-92. (2013)). My work on the characterization of the GPCR heteromer interface interaction has been pioneering in the field. I have described the interface interaction of the D2R-A2AR heterodimer and later on the interface interactions of the M5-M3, 5-HT1A-FGFR1 and the GalR1-GalR2 heteroreceptor complexes, demonstrating their potential use as drug targets by means of the use of small interfering peptides (Borroto-Escuela et al., BBRC.; 394(1):222-7 (2010), Borroto-Escuela et al., Biochim Biophys Acta.;1803(7):813-25. (2010) and Borroto-Escuela et al., BBRC.;402(4):801-7.(2010)). The most important impact of my research has been on the discovery of the existence of GPCR-GPCR and GPCR-RTK receptor-receptor interactions in the CNS and the characterization of their interface interactions (Borroto-Escuela et al., IUBMB Life; 63(7):463-72 (2011)).
Load more

Recommended publications
  • Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
    REVIEW published: 21 February 2017 doi: 10.3389/fncel.2017.00037 Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease Dasiel O. Borroto-Escuela 1,2,3, Jens Carlsson 4, Patricia Ambrogini 2, Manuel Narváez 5, Karolina Wydra 6, Alexander O. Tarakanov 7, Xiang Li 1, Carmelo Millón 5, Luca Ferraro 8, Riccardo Cuppini 2, Sergio Tanganelli 9, Fang Liu 10, Malgorzata Filip 6, Zaida Diaz-Cabiale 5 and Kjell Fuxe 1* 1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden, 2Department of Biomolecular Science, Section of Physiology, University of Urbino, Urbino, Italy, 3Observatorio Cubano de Neurociencias, Grupo Bohío-Estudio, Yaguajay, Cuba, 4Department of Cell and Molecular Biology, Uppsala Biomedical Centre (BMC), Uppsala University, Uppsala, Sweden, 5Facultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Málaga, Spain, 6Laboratory of Drug Addiction Pharmacology, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland, 7St. Petersburg Institute for Informatics and Automation, Russian Academy of Sciences, Saint Petersburg, Russia, 8Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy, 9Department of Medical Sciences, University of Ferrara, Ferrara, Italy, 10Campbell Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada The introduction of allosteric receptor–receptor interactions in G protein-coupled receptor (GPCR) heteroreceptor complexes of the central nervous system (CNS) gave a new dimension to brain integration and neuropsychopharmacology. The molecular basis Edited by: Hansen Wang, of learning and memory was proposed to be based on the reorganization of the homo- University of Toronto, Canada and heteroreceptor complexes in the postjunctional membrane of synapses.
    [Show full text]
  • Regulation of Ion Channels by Muscarinic Receptors
    Regulation of ion channels by muscarinic receptors David A. Brown Department of Neuroscience, Physiology & Pharmacology, University College London, London, WC1E 6BT (UK). Contact address: Professor D.A.Brown, FRS, Department of Neuroscience, Physiology & Pharmacology, University College London, Gower Street, Londin, WC1E 6BT. E-mail: [email protected] Telephone: (+44) (0)20 7679 7297 Mobile (for urgent messages): (+44)(0)7766-236330 Abstract The excitable behaviour of neurons is determined by the activity of their endogenous membrane ion channels. Since muscarinic receptors are not themselves ion channels, the acute effects of muscarinic receptor stimulation on neuronal function are governed by the effects of the receptors on these endogenous neuronal ion channels. This review considers some principles and factors determining the interaction between subtypes and classes of muscarinic receptors with neuronal ion channels, and summarizes the effects of muscarinic receptor stimulation on a number of different channels, the mechanisms of receptor – channel transduction and their direct consequences for neuronal activity. Ion channels considered include potassium channels (voltage-gated, inward rectifier and calcium activated), voltage-gated calcium channels, cation channels and chloride channels. Key words: Ion channels; neuronal excitation and inhibition; pre- and postsynaptic events; muscarinic receptor subtypes; G proteins; transduction mechanisms. Contents. 1. Introduction: some principles of muscarinic receptor – ion channel coupling. 1.2 Some consequences of the indirect link between receptor and ion channel. + The connection between M1Rs and the M-type K channel as a model system 1.2.1 Dynamics of the response 1.2.2 Sensitivity of the response to agonist stimulation 2. Some muscarinic receptor-modulated neural ion channels.
    [Show full text]
  • Monoaminergic Neuromodulation of Sensory Processing
    fncir-12-00051 July 6, 2018 Time: 17:34 # 1 REVIEW published: 10 July 2018 doi: 10.3389/fncir.2018.00051 Monoaminergic Neuromodulation of Sensory Processing Simon N. Jacob1* and Hendrikje Nienborg2* 1 Department of Neurosurgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany, 2 Werner Reichardt Centre for Integrative Neuroscience, University of Tübingen, Tübingen, Germany All neuronal circuits are subject to neuromodulation. Modulatory effects on neuronal processing and resulting behavioral changes are most commonly reported for higher order cognitive brain functions. Comparatively little is known about how neuromodulators shape processing in sensory brain areas that provide the signals for downstream regions to operate on. In this article, we review the current knowledge about how the monoamine neuromodulators serotonin, dopamine and noradrenaline influence the representation of sensory stimuli in the mammalian sensory system. We review the functional organization of the monoaminergic brainstem neuromodulatory systems in relation to their role for sensory processing and summarize recent neurophysiological evidence showing that monoamines have diverse effects on early sensory processing, including changes in gain and in the precision of neuronal responses to sensory inputs. We also highlight the substantial evidence for complementarity between these neuromodulatory systems with different patterns of Edited by: innervation across brain areas and cortical layers as well as distinct neuromodulatory Anita Disney, actions. Studying the effects of neuromodulators at various target sites is a crucial step Vanderbilt University, United States in the development of a mechanistic understanding of neuronal information processing Reviewed by: Summer Sheremata, in the healthy brain and in the generation and maintenance of mental diseases.
    [Show full text]
  • Biased Receptor Functionality Versus Biased Agonism in G-Protein-Coupled Receptors Journal Xyz 2017; 1 (2): 122–135
    BioMol Concepts 2018; 9: 143–154 Review Open Access Rafael Franco*, David Aguinaga, Jasmina Jiménez, Jaume Lillo, Eva Martínez-Pinilla*#, Gemma Navarro# Biased receptor functionality versus biased agonism in G-protein-coupled receptors Journal xyz 2017; 1 (2): 122–135 https://doi.org/10.1515/bmc-2018-0013 b-arrestins or calcium sensors are also provided. Each of receivedThe FirstJuly 19, Decade 2018; accepted (1964-1972) November 2, 2018. the functional GPCR units (which are finite in number) has Abstract:Research Functional Article selectivity is a property of G-protein- a specific conformation. Binding of agonist to a specific coupled receptors (GPCRs) by which activation by conformation, i.e. GPCR activation, is sensitive to the differentMax Musterman, agonists leads Paul to differentPlaceholder signal transduction kinetics of the agonist-receptor interactions. All these mechanisms. This phenomenon is also known as biased players are involved in the contrasting outputs obtained agonismWhat and Is has So attracted Different the interest Aboutof drug discovery when different agonists are assayed. programsNeuroenhancement? in both academy and industry. This relatively recent concept has raised concerns as to the validity and Keywords: conformational landscape; GPCR heteromer; realWas translational ist so value anders of the results am showing Neuroenhancement? bias; firstly cytocrin; effectors; dimer; oligomer; structure. biased agonism may vary significantly depending on the cellPharmacological type and the experimental and Mental constraints,
    [Show full text]
  • Anatomy and Physiology of Me- Tabotropic Glutamate Receptors in Mammalian and Avian Audi- Tory System
    Zheng-Quan Tang and Lu Y, Trends Anat Physiol 2018, 1: 001 DOI: 10.24966/TAP-7752/100001 HSOA Trends in Anatomy and Physiology Review Article Abbreviations Anatomy and Physiology of Me- AC: Auditory Cortex tabotropic Glutamate Receptors AVCN: Anteroventral Cochlear Nucleus CN: Cochlear Nucleus in Mammalian and Avian Audi- DCN: Dorsal Cochlear Nucleus EPSC/P: Excitatory Postsynaptic Current/Potential GABA R: GABA Receptor tory System B B + Zheng-Quan Tang1 and Yong Lu2* GIRK: G-Protein- Coupled Inward Rectifier K HF: High-Frequency 1Oregon Hearing Research Center, Vollum Institute, Oregon Health and IC: Inferior Colliculus Science University, Oregon, USA IGluR: Ionotropic Glutamate Receptor 2Department of Anatomy and Neurobiology, Northeast Ohio Medical IHC: Inner Hair Cell University, Ohio, USA IPSC/P: Inhibitory Postsynaptic Current/Potential LF: Low Frequency LSO: Lateral Superior Live LTD/P: Long-Term Depression/Potentiation MF: Middle-Frequency MGB: Medial Geniculate Body mGluR: Metabotropic Glutamate Receptor MNTB: Medial Nucleus of Trapezoid Body MSO: Medial Superior Olive Abstract mRNA: Messenger Ribonucleic Acid Glutamate, as the major excitatory neurotransmitter used in the NA: Nucleus Angularis vertebrate brain, activates ionotropic and metabotropic glutamate NL: Nucleus Laminaris receptors (iGluRs and mGluRs), which mediate fast and slow neu- NM: Nucleus Magnocellularis ronal actions, respectively. mGluRs play important modulatory roles OHC: Outer Hair Cell in many brain areas, forming potential targets for drugs developed PVCN: Posteroventral Cochlear Nucleus to treat brain disorders. Here, we review studies on mGluRs in the mammalian and avian auditory system. Although anatomical expres- SON: Superior Olivary Nucleus sion of mGluRs in the cochlear nucleus has been well character- VCN: Ventral Cochlear Nucleus ized, data for other auditory nuclei await more systematic investi- VGCC: Voltage-Gated Ca2+ Channel gations especially at the electron microscopy level.
    [Show full text]
  • Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain
    Neuropsychopharmacology (2009) 34, 651–661 & 2009 Nature Publishing Group All rights reserved 0893-133X/09 $32.00 www.neuropsychopharmacology.org Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain ,1 1 1,2 O Chernoloz* , M El Mansari and P Blier 1 2 Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ontario, Canada Pramipexole (PPX) is a D2/D3 receptor agonist that has been shown to be effective in the treatment of depression. Serotonin (5-HT), norepinephrine (NE) and dopamine (DA) systems are known to be involved in the pathophysiology and treatment of depression. Due to reciprocal interactions between these neuronal systems, drugs selectively targeting one system-specific receptor can indirectly modify the firing activity of neurons that contribute to firing patterns in systems that operate via different neurotransmitters. It was thus hypothesized that PPX would alter the firing rate of DA, NE and 5-HT neurons. To test this hypothesis, electrophysiological experiments were carried out in anesthetized rats. Subcutaneously implanted osmotic minipumps delivered PPX at a dose of 1 mg/kg per day for 2 or 14 days. After a 2-day treatment with PPX the spontaneous neuronal firing of DA neurons was decreased by 40%, NE neuronal firing by 33% and the firing rate of 5-HT neurons remained unaltered. After 14 days of PPX treatment, the firing rate of DA had recovered as well as that of NE, whereas the firing rate of 5-HT neurons was increased by 38%.
    [Show full text]
  • Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
    medicines Review Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects Victoria Harwell and Pius S. Fasinu * Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27501, USA; [email protected] * Correspondence: [email protected] Received: 28 July 2020; Accepted: 27 August 2020; Published: 1 September 2020 Abstract: Background: Besides its well-known role as a peripheral chemical mediator of immune, vascular, and cellular responses, histamine plays major roles in the central nervous system, particularly in the mediation of arousal and cognition-enhancement. These central effects are mediated by the histamine-3 auto receptors, the modulation of which is thought to be beneficial for the treatment of disorders that impair cognition or manifest with excessive daytime sleepiness. Methods: A database search of PubMed, Google Scholar, and clinicaltrials.gov was performed in June 2020. Full-text articles were screened and reviewed to provide an update on pitolisant and other histamine-3 receptor antagonists. Results: A new class of drugs—histamine-3 receptor antagonists—has emerged with the approval of pitolisant for the treatment of narcolepsy with or without cataplexy. At the recommended dose, pitolisant is well tolerated and effective. It has also been evaluated for potential therapeutic benefit in Parkinson disease, epilepsy, attention deficit hyperactivity disorder, Alzheimer’s disease, and dementia. Limited
    [Show full text]
  • The Histamine H3 Receptor: Structure, Pharmacology, and Function
    1521-0111/90/5/649–673$25.00 http://dx.doi.org/10.1124/mol.116.104752 MOLECULAR PHARMACOLOGY Mol Pharmacol 90:649–673, November 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW—A LATIN AMERICAN PERSPECTIVE ON G PROTEIN-COUPLED RECEPTORS The Histamine H3 Receptor: Structure, Pharmacology, and Function Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa, and José-Antonio Arias-Montaño Downloaded from Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados (Cinvestav-IPN), Zacatenco, Ciudad de México, México Received April 15, 2016; accepted August 24, 2016 ABSTRACT molpharm.aspetjournals.org Among the four G protein–coupled receptors (H1–H4)identified characteristics of the H3R, namely, its structure, constitutive as mediators of the biologic effects of histamine, the H3 activity, isoforms, signal transduction pathways, regional dif- receptor (H3R) is distinguished for its almost exclusive expres- ferences in expression and localization, selective agonists, sion in the nervous system and the large variety of isoforms antagonists and inverse agonists, dimerization with other generated by alternative splicing of the corresponding mRNA. neurotransmitter receptors, and the main presynaptic and post- Additionally, it exhibits dual functionality as autoreceptor and synaptic effects resulting from its activation. The H3Rhas heteroreceptor, and this enables H3Rs to modulate the hista- attracted interest as a potential drug target for the treatment of minergic and other neurotransmitter systems. The cloning of the several important neurologic and psychiatric disorders, such H3R cDNA in 1999 by Lovenberg et al. allowed for detailed as Alzheimer and Parkinson diseases, Gilles de la Tourette studies of its molecular aspects.
    [Show full text]
  • Targeting Presynaptic H3 Heteroreceptor in Nucleus Accumbens to Improve Anxiety and Obsessive-Compulsive-Like Behaviors
    Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors Xiao-Yang Zhanga,b,1, Shi-Yu Penga,1,2, Li-Ping Shena,1, Qian-Xing Zhuanga,1,3, Bin Lia,4,5, Shu-Tao Xiea, Qian-Xiao Lia, Ming-Run Shia, Tian-Yu Maa, Qipeng Zhanga,b, Jian-Jun Wanga,b, and Jing-Ning Zhua,b,5 aState Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, School of Life Sciences, Nanjing University, Nanjing 210023, China; and bInstitute for Brain Sciences, Nanjing University, Nanjing 210023, China Edited by Lily Yeh Jan, University of California, San Francisco, CA, and approved November 9, 2020 (received for review April 30, 2020) Anxiety commonly co‐occurs with obsessive-compulsive disorder compulsive symptoms in OCD patients (9, 10). More importantly, (OCD). Both of them are closely related to stress. However, the deep brain stimulation (DBS) targeting the NAc core has been shared neurobiological substrates and therapeutic targets remain foundtoimproveobsessive-compulsive symptoms and decrease unclear. Here we report an amelioration of both anxiety and OCD ratings of anxiety in patients suffering from treatment-resistant via the histamine presynaptic H3 heteroreceptor on glutamatergic OCD or depression (11, 12). Therefore, NAc core may be a po- afferent terminals from the prelimbic prefrontal cortex (PrL) to the tentialcommonneuralsubstratefor the clinical and neuropatho- nucleus accumbens (NAc) core, a vital node in the limbic loop. The logical overlap between anxiety and OCD. NAc
    [Show full text]
  • Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases
    cells Review Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases Dasiel O. Borroto-Escuela 1,2,3,* , Patrizia Ambrogini 2 , Manuel Narvaez 3 , Valentina Di Liberto 4, Sarah Beggiato 5, Luca Ferraro 6 , Ramon Fores-Pons 1,3, Jose E. Alvarez-Contino 1,7, Alexander Lopez-Salas 1,3, Giuseppa Mudò 4 , Zaida Díaz-Cabiale 3 and Kjell Fuxe 1,* 1 Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden; [email protected] (R.F.-P.); [email protected] (J.E.A.-C.); [email protected] (A.L.-S.) 2 Department of Biomolecular Science Section of Morphology, Physiology and Environmental Biology, Campus Scientifico Enrico Mattei, via Ca’ le Suore 2, 61029 Urbino, Italy; [email protected] 3 Facultad de Medicina, Instituto de Investigacion de Málaga, Universidad de Malaga, Campus de Teatinos s/n, 29071 Málaga, Spain; [email protected] (M.N.); [email protected] (Z.D.-C.) 4 Department of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90134 Palermo, Italy; [email protected] (V.D.L.); [email protected] (G.M.) 5 Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, 66100 Chieti, Italy; [email protected] 6 Department of Life Sciences and Biotechnology and LTTA Center, University of Ferrara, 44121 Ferrara, Italy; [email protected] 7 Department of Education, School of Medicine, Villa Clara University of Medical Sciences, Polyclinic Juan Citation: Borroto-Escuela, D.O.; Bruno Zayas, 52900 Cifuentes, Cuba Ambrogini, P.; Narvaez, M.; Di * Correspondence: [email protected] (D.O.B.-E.); [email protected] (K.F.); Tel.: +46-760396319 (D.O.B.-E.) Liberto, V.; Beggiato, S.; Ferraro, L.; Fores-Pons, R.; Alvarez-Contino, J.E.; Abstract: The heteroreceptor complexes present a novel biological principle for signal integration.
    [Show full text]
  • Receptor-Receptor Interactions in Heteroreceptor Complexes: a New Principle in Biology
    Neuroscience Discovery ISSN 2052-6946 | Volume 2 | Article 6 Review Open Access Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory Kjell Fuxe1*, Dasiel O. Borroto-Escuela1, Francisco Ciruela2, Diego Guidolin3 and Luigi F. Agnati4 CrossMark *Correspondence: [email protected] ← Click for updates 1Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. 2 Pharmacology Unit, Faculty of Medicine, Department of Pathology and Experimental Therapeutics, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. 3Department of Molecular Medicine, University of Padova, Padua, Italy. 4Department of Biomedical Sciences, University of Modena, Modena, Italy. Abstract The allosteric receptor-receptor interactions over the interfaces in heteroreceptor complexes have been explored and their biochemical, pharmacological and functional integrative implications in the Central Nervous System (CNS) described. GPCR interacting proteins participate in these complexes mainly through modulation of receptor-receptor interactions. Methodologies to study heteroreceptor complexes in living cells (FRET and BRET-based techniques) and in brain tissue (in situ proximity ligation assay) are briefly summarized. The physiological and pathological relevance of the allosteric receptor-receptor interactions in heteroreceptor complexes is emphasized and novel strategies for treatment of mental and neurological disease are developed based on this new biological principle of integration.
    [Show full text]
  • Neuromodulation Via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies
    fncir-12-00005 February 1, 2018 Time: 17:58 # 1 REVIEW published: 05 February 2018 doi: 10.3389/fncir.2018.00005 Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies Andreas Bjorefeldt1,2*, Sebastian Illes1, Henrik Zetterberg3,4,5,6 and Eric Hanse1 1 Department of Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden, 2 Department of Neuroscience, Brown University, Providence, RI, United States, 3 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden, 4 Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden, 5 Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London, United Kingdom, 6 United Kingdom Dementia Research Institute, University College London, London, United Kingdom The cerebrospinal fluid (CSF) occupies the brain’s ventricles and subarachnoid space and, together with the interstitial fluid (ISF), forms a continuous fluidic network that bathes all cells of the central nervous system (CNS). As such, the CSF is well positioned to actively distribute neuromodulators to neural circuits in vivo via volume transmission. Recent in vitro experimental work in brain slices and neuronal cultures has shown that human CSF indeed contains neuromodulators that strongly influence neuronal activity. Here we briefly summarize these new findings and discuss their potential relevance to neural circuits in health and disease. Edited by: Keywords: cerebrospinal fluid, neuromodulation, neural circuit Srikanth Ramaswamy, École Polytechnique Fédérale de Lausanne, Switzerland INTRODUCTION Reviewed by: Graham William Knott, École Polytechnique Fédérale The cerebrospinal fluid (CSF) system is an evolutionarily preserved feature of animal brains de Lausanne, Switzerland (Brocklehurst, 1979) and provides central neurons with a regulated chemical environment well Dasiel Oscar Borroto-Escuela, suited to promote their function and survival.
    [Show full text]